Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  6. News
  7. Summary
    300760   CNE100003G67

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

(300760)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Mindray Unveils Nuewa I9, A New Ob/GYN Diagnostic Ultrasound System

06/08/2021 | 03:45am EDT

Mindray has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN). Committed to inspiring women's healthcare, Mindray's Nuewa I9 elevates scanning capacity to new levels by combining innovative design and exceptional imaging quality with the latest technologies.Moreover, following the strategic acquisition of the Company's 200,000 m2 land parcel in the B?cancour Industrial Park, ground works were initiated to establish the environmental baseline of the site and geotechnical data will be gathered during the summer to complete the work realized in 2020. Nuewa I9 boasts a well-thought-out design for the ultimate convenience. Its foldable height and compact body allow the system to easily pass through doors for quick access across departments. Meanwhile, the breakthrough exam-specific iConsole control panel is optimized to adapt to different clinical scenarios, and its E-ink keys can be easily customized for the most frequently used functions. The entire solution is powered by Mindray's revolutionary ZST+ platform, which overcomes traditional trade-off limitations to deliver exceptional image quality for infinite imaging solutions with non-stop improvements. Nuewa I9 is also packed with automated tools to improve workflow and efficiency in women's and neonatal care, such as Smart-VTrace, Smart Pelvic and Smart Hip. One of the biggest innovations featured in Mindray's Nuewa I9 is Smart Scene 3D, a scenario-oriented volume scan technique that enables the automatic identification of tissue characteristics and provides an organ-specific diagnosis. The technology supports the whole examination procedure starting with auto clinical scenario identification, then harnesses automation at every point from imaging optimization to plane acquisition, quantification, and the creation of an automated workflow. As a result, Nuewa I9 alleviates the workload of manual operation; reduces scanning time for individual patients; and delivers a truly easy, accurate and fast diagnosis. Nuewa I9 also makes 3D/4D interactions extremely intuitive with reduced knob adjustments. Clinicians need only to click and choose their desired effect for different application scenarios, such as Routine, iLive, Bone, Tissue, and Follicle. Preset imaging settings have been integrated in the system for optimal volume imaging effects, and support ease of use in every possible clinical scenario for OB/GYN.


© S&P Capital IQ 2021
All news about SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
09/10Mindray Announces the Launch of its Latest Point-Of-Care Ultrasound System, t..
CI
09/02Tranche Update on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Equity..
CI
09/01Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Equity Buyback announced..
CI
08/25Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announces an Equity Buybac..
CI
08/25Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results f..
CI
08/24Shenzhen Mindray Bio-Medical Electronics Co., Ltd. authorizes a Buyback Plan.
CI
06/08Mindray Unveils Nuewa I9, A New Ob/GYN Diagnostic Ultrasound System
CI
06/02Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging
CI
05/30Mindray Defines Future of Imaging Technologies with New General Imaging, Wome..
CI
05/20Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for..
CI
More news
Analyst Recommendations on SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
More recommendations
Financials
Sales 2021 25 732 M 3 992 M 3 992 M
Net income 2021 8 280 M 1 284 M 1 284 M
Net cash 2021 19 940 M 3 093 M 3 093 M
P/E ratio 2021 48,2x
Yield 2021 0,71%
Capitalization 399 B 62 084 M 61 951 M
EV / Sales 2021 14,7x
EV / Sales 2022 11,9x
Nbr of Employees 11 833
Free-Float 100%
Chart SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Duration : Period :
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 328,50 CNY
Average target price 476,86 CNY
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Ming He Cheng General Manager & Director
Xi Ting Li Chairman
Zhi Tang Chairman-Supervisory Board
Hao Xi Independent Director
Hang Xu Director
Sector and Competitors